Dr. Hui-ting Xu | Gene Regulation | Best Researcher Award

Yancheng Teachers University |  China

Author Profile

Scopus

Orcid ID

🧬 HUI-TING XU: A RISING STAR IN BIOPHYSICAL COMPUTATION

📘 EARLY ACADEMIC PURSUITS

HUI-TING XU, born in 1997, is a promising Chinese scholar whose academic journey began with a profound interest in biophysics and theoretical modeling. She earned her Ph.D. in 2023 from Beijing Normal University, a prestigious institution known for its emphasis on research excellence. Her doctoral work laid the foundation for her specialization in biophysical computation, particularly in the domain of DNA conformational dynamics and ionic interactions.

🎓 PROFESSIONAL ENDEAVORS

Since 2023, Dr. Xu has been serving as a Lecturer at Yancheng Teachers University. In her short academic career, she has demonstrated a strong command over advanced molecular simulation software, including GROMACS, CHARMM, and NAMD, and continues to apply these tools in groundbreaking research. Despite her early-career status, she is actively shaping the scientific discourse in biophysical theory and computation.

🔬 CONTRIBUTIONS AND RESEARCH FOCUS ON GENE REGULATION

Dr. Hui-ting Xu has dedicated her research to unraveling the physicochemical principles governing DNA structure and ionic interactions. Her major contributions include:

• Revealing the ion-specific binding law for biologically significant ions such as Na⁺, K⁺, Ca²⁺, and Mg²⁺.

• Exploring the synergistic effect of the solvation layer in DNA stability and interaction.

• Demonstrating how base sequences regulate DNA conformational transitions (notably the shift from B-form to A-form DNA).

Her work bridges computational physics and molecular biology, offering valuable insights into the structural behavior of genetic material under various ionic environments.

🌍 IMPACT AND INFLUENCE

Hui-ting Xu’s research has gained recognition in multiple authoritative international journals, reflecting her influence in the scientific community. She is an active member of the Second Board of Directors of the Radiation Beam Technology Branch of the Chinese Nuclear Society, showcasing her engagement beyond pure academia into applied nuclear and radiation technologies.

Her innovative approach contributes significantly to both fundamental science and applied medical research, especially in the context of genetic regulation and genomic structure-function analysis.

📊 ACADEMIC CITATIONS

Dr. Xu’s publications have appeared in notable journals such as:

• Results in Chemistry (2025)

• Springer Proceedings in Physics (2022, 2025)

• Journal of Molecular Liquids (2021)

• Chemical Physics Letters (2020)

She has authored or co-authored six research papers, with four as the first author, signifying her leading role in high-quality publications.

Key DOIs:

• DOI:10.1016/j.rechem.2025.102290

• DOI:10.1007/978-3-030-80924-9_7

🧪 LEGACY AND FUTURE CONTRIBUTIONS

Though early in her career, Hui-ting Xu has already made substantial contributions to the field of computational biophysics. Her unique insights into ionic atmospheres and DNA dynamics are expected to pave the way for novel breakthroughs in genomic stability, gene therapy, and biotechnological applications.

Looking ahead, her mastery of simulation tools and commitment to uncovering fundamental biophysical laws position her as a future leader in computational life sciences. She is also likely to mentor the next generation of physicists and computational biologists at Yancheng Teachers University and beyond.

🏅 AWARD NOMINATION HIGHLIGHT

Dr. Hui-ting Xu is a strong candidate for the Best Researcher Award for her innovative and impactful research contributions in biophysical computation, particularly in DNA structural dynamics and ion interaction modeling.

📑NOTABLE PUBLICATIONS

"Theoretical study of the sequence-dependent distribution of Na+ ions around DNA" 

• Author: Hui-ting Xu; Xiao-wei Jiang; Yu-jie Song; Bin Gu
• Journal: Results in Chemistry
• Year: 2025

"The Influence of Sequence Dependence and External Solvents on DNA Conformation" 

• Authors: Hui-Ting Xu; Nan Zhang; Ming-Ru Li; Feng-Shou Zhang
• Journal: Springer Proceedings in Physics
• Year: 2022

"Comparison of the ionic effects of Ca2+ and Mg2+ on nucleic acids in liquids" 

• Authors: Hui-Ting Xu; Nan Zhang; Ming-Ru Li; Feng-Shou Zhang
• Journal: Journal of Molecular Liquids
• Year: 2021

"Anion effect of Cl−, I−, and F− on counterions condensation within nucleic acid ion atmosphere" 

• Authors: Hui-Ting Xu; Nan Zhang; Ming-Ru Li; Feng-Shou Zhang
• Journal: Journal of Molecular Liquids
• Year: 2021

Dr. Tianao Xie | Oncology | Best Researcher Award

Zhejiang University | China

Author Profile

Scopus

🌟 BIOGRAPHY OF XIE TIANAO: A RISING STAR IN MEDICAL RESEARCH & SURGERY 🌟

🎓 EARLY ACADEMIC PURSUITS

XIE TIANAO began his academic journey in 2017 at Guangzhou Medical University, where he completed his undergraduate studies in June 2022. Driven by an early passion for medical science and research, he continued his educational trajectory at the prestigious Zhejiang University under the mentorship of Prof. Cai Xiujun, pursuing a Master of Science in Surgery (2022–2025).

His early academic record was distinguished by consistent excellence, culminating in multiple National Scholarships for both undergraduate and graduate studies. These recognitions reflect not only academic proficiency but also his commitment to innovation and leadership.

👨‍⚕️ PROFESSIONAL ENDEAVORS

Xie has seamlessly blended academic training with meaningful clinical and research work. He has taken on several leadership roles, including:

• President of the Graduate Student Association

• Lecturer at the Third Clinical Medical College

• Key speaker at academic conferences like the “Shao Medical Research and Sharing Conference”

• Host and organizer of employment lectures and cultural/sports activities

His involvement extended beyond the classroom, marking him as a proactive leader, educator, and mentor among peers.

🔬 CONTRIBUTIONS AND RESEARCH FOCUS ON ONCOLOGY

Xie Tianao’s research portfolio is impressive and spans critical areas in oncology, immunotherapy, bioinformatics, nanomedicine, and AI in medicine. His research contributions include:

• Nanoparticle and MOF-based cancer therapy

• Deep tumor photodynamic therapy

• AI applications in fatty liver disease diagnosis

• Immune cell metabolism and precision immunotherapy

• Mendelian randomization studies on cachexia and glycemic metabolism

• SARS-CoV-2 bioinformatics research

• Copper-induced immunotherapy for liver cancer

His ongoing and published work clearly reflects a focus on translational medicine and cutting-edge therapeutic technologies.

📚 ACADEMIC CITES AND PUBLICATIONS

Xie has authored 13 SCI-indexed papers, of which 10 list him as a first or co-first author. Notable highlights include:

• Highest single-article Impact Factor: 19.87

• Cumulative Impact Factor: 90+

Notable Publications:

• Sci Bull (IF: 19.87) – Adavosertib-encapsulated MOFs for p53-mutated gallbladder cancer

• Nat Commun (IF: 14.7) – Persistent luminescence nanoparticles for deep tumor PDT

• Adv Sci (IF: 12.84) – Neutrophil monitoring via microneedle patch

• Biomark Res (IF: 11.1) – Lipid metabolism in tumor-infiltrating regulatory T cells

• Mater Design (IF: 8.4) – Au NP enzyme-like activity

• Hepatol Int (IF: 5.9) – AI trends in fatty liver diseases

• J Cell Mol Med (IF: 5.31) – SARS-CoV-2 infection mechanisms

• Med Plus – Mendelian randomization study on cachexia

🌍 IMPACT AND INFLUENCE

Xie’s work has generated broad academic interest and made meaningful contributions to:

• Precision oncology and synthetic lethality

• Targeted drug delivery using smart nanomaterials

• Development of AI diagnostic tools

• Bioinformatics-driven understanding of viral infections

His contributions are already shaping future treatment modalities and offer practical frameworks for solving real-world medical problems.

🏅 HONORS AND AWARDS

National Level:

• National Undergraduate Scholarship

• National Graduate Scholarship

University/School Level:

• Five-Good Graduate Student

• Outstanding Graduate Student (2x)

• Outstanding Student Leader (2x)

• First & Second Prize Scholarships

Academic Competitions:

• Second Prize – Zhejiang University Jiang Zhi Research Award (2023 & 2024)

• Third Prize – Zhejiang "Dandelion" Entrepreneurship Competition

🧪 SCIENTIFIC RESEARCH PROJECTS

Key Projects:

• 🔬 Switchable Persistent Luminescence for Immuno-PDT – Nature Communications (IF: 14.78) – in revision

• 💊 Intracellular Copper Reservoir for Liver Cancer Immunotherapy – Small (IF: 13.0) – First author, in revision

• 🔍 Synthetic Lethality in p53-Mutated Tumors – National level

• 🧠 Intelligent Cancer Drug Delivery System – Provincial level – Main author

🧠 SKILLS AND CERTIFICATIONS

• Medical Licensure – Certified Medical Practitioner

• Language Proficiency – CET-6: 554

• Software – Skilled in PS, AI, Prism, Origin

• Computer Literacy – Level 2 Certified

🔮 LEGACY AND FUTURE CONTRIBUTIONS

Xie Tianao’s ongoing research holds transformative potential in several interdisciplinary domains. His pioneering focus on AI-assisted diagnostics, synthetic lethality-based oncology, and nanotechnology-enhanced therapies promises to usher in new treatment paradigms. With ongoing work poised for publication in high-impact journals and a career trajectory aligned with translational excellence, Xie is on the path to becoming a key figure in medical innovation in China and globally.

His vision, scientific acumen, and leadership set a strong foundation for a lasting legacy in clinical translational medicine, oncology, and bioengineering.

🏆 CONCLUSION

🔹 XIE TIANAO is a promising young clinical researcher and medical innovator, whose body of work already demonstrates both depth and impact. With an exceptional record in surgical science, translational research, and academic leadership, he is an ideal nominee for the Best Researcher Award and a future leader in global medical science.

📑NOTABLE PUBLICATIONS

"Trends in the Applications of Artificial Intelligence in Fatty Liver Diseases" 

• Author: Xie TA,
• Journal: Hepatology International
• Year: 2025

"Microneedle Patch for In Situ Neutrophil Monitoring" 

• Authors: Y, Cai RS, Xie TA
• Journal: Advanced Science
• Year: 2025

Prof. Dr. Zuojie Luo | Endocrinology | Best Researcher Award

The First Affiliated Hospital of Guangxi Medical University | China

Author Profile

Scopus

Orcid ID

👨‍⚕️ PROFESSOR ZUOJIE LUO: A PIONEERING ENDOCRINOLOGIST IN CHINA

           Renowned for his contributions to diabetes research and endocrinology education

📘 EARLY ACADEMIC PURSUITS

Dr. Zuojie Luo began his medical journey at Guangxi Medical University, earning his M.D. in 1983. His thirst for advanced knowledge led him to complete postgraduate courses in medicine (1997–1998) and English language training (2002–2003) at Guangxi University, where he became fluent in English—an asset that later supported his international academic engagements.

A milestone in his academic growth was his postdoctoral research fellowship at the prestigious Joslin Diabetes Center, Harvard Medical School (2004–2005), one of the world’s top institutions for diabetes research.

💼 PROFESSIONAL ENDEAVORS

Dr. Luo has held a series of progressively senior roles at The First Affiliated Hospital of Guangxi Medical University:

• Assistant and Resident Physician (1983–1988)

• Lecturer of Endocrinology (1988–1993)

• Associate Professor and Vice Director (1994–1999)

• Professor and Director of Endocrinology (1999–Present)

His international footprint includes his tenure as a Visiting Professor at Harvard University (2004–2005), enriching his academic and research perspectives on a global stage.

In addition, Dr. Luo serves as Deputy Academic Provost of Guangxi Medical University since 2005, where he plays a pivotal role in shaping academic strategies.

🔬 CONTRIBUTIONS AND RESEARCH FOCUS ON ENDOCRINOLOGY

Dr. Luo has centered his research on endocrinology, with a deep focus on diabetes and metabolic disorders. His training at the Joslin Diabetes Center—a global leader in diabetes care—equipped him with cutting-edge expertise that he brought back to China to develop clinical protocols and research programs.

He has published approximately 120 research papers, contributing significantly to clinical and experimental endocrinology.

🌏 IMPACT AND INFLUENCE

Dr. Luo is widely respected as an academic leader and healthcare educator. His dual roles as Department Director and University Provost have enabled him to:

• Influence thousands of students and junior physicians in China.

• Lead national academic discourse through his Chairpersonship of the Guangxi Branch of the Chinese Medical Association (CMA).

• Serve on the National Committee of the Society of Endocrinology, CMA, advancing medical policy and professional standards in China.

📊 ACADEMIC CITES

With around 120 journal publications, Dr. Luo's work is cited in both national and international medical literature, contributing to ongoing research in:

• Diabetes pathophysiology

• Hormonal regulation

• Clinical treatment protocols in endocrinology

While citation metrics are not provided, his long-standing academic and clinical influence in China and his training at Harvard underscore his high standing in the research community.

🏅 LEGACY AND FUTURE CONTRIBUTIONS

Dr. Luo’s legacy lies in:

• Mentoring generations of endocrinologists in Guangxi and beyond.

• Bridging international collaboration, especially between Chinese and American institutions.

• Elevating medical education and research quality at Guangxi Medical University.

In the coming years, his ongoing leadership and academic roles suggest a strong potential for continued influence in policy-making, institutional development, and cross-border research collaborations in endocrinology and diabetes.

📝 OTHER SIGNIFICANT ROLES AND HONORS

• “Outstanding Teacher” Award, Guangxi Medical University (1999–2001)

• Standing Member & Secretary of Endocrinology, Guangxi CMA (1997–2003)

• Chairperson, Guangxi Branch of the Chinese Medical Association (2003–Present)

🔚 CONCLUSION

Professor Zuojie Luo represents the ideal synthesis of clinical expertise, academic leadership, and international collaboration. As one of China’s senior-most endocrinologists with Harvard training and a prolific publication record, his career is a model for aspiring physician-scientists committed to advancing medical science and healthcare.

📑NOTABLE PUBLICATIONS

"Exploring the mechanism of comorbidity in patients with T1DM and COVID-19: Integrating bioinformatics and Mendelian randomization methods" 

• Authors: Tingliang Wang; Yun Zhang; Chunjiao Wu; Zhenxing Huang; Xinghuan Liang; Zuojie Luo
• Journal: Medicine
• Year: 2024

"Remnant cholesterol is more positively related to diabetes, prediabetes, and insulin resistance than conventional lipid parameters and lipid ratios: A multicenter, large sample survey" 

• Authors: Binqi Li; Yang Liu; Xin Zhou; Lulu Chen; Li Yan; Xulei Tang; Zhengnan Gao; Qin Wan; Zuojie Luo
• Journal: Journal of Diabetes
• Year: 2024

"Thyroid dysfunction and risk of different types of dementia: A systematic review and meta-analysis" 

• Authors: Jianbo Ye; Zhenxing Huang; Chunfeng Liang; Zhang Yun; Lili Huang; Yuping Liu; Zuojie Luo
• Journal: Medicine
• Year: 2024

"Prognostic value and immune infiltration of the NEK family in clear cell renal cell carcinoma" 

• Authors: Yingli Zhu; Jianfan Lin; Yufei Li; Zuojie Luo
• Journal: Medicine
• Year: 2024

"Causality of blood metabolites and metabolic pathways on Graves’ disease and Graves’ ophthalmopathy: a two-sample Mendelian randomization study" 

• Authors: Tingliang Wang; Yun Zhang; Chunjiao Wu; Haiyan Yang; Zuojie Luo
• Journal: Medicine
• Year: 2024

Prof. Min Chen | Inflammatory Bowel Disease | Best Researcher Award

Xijing Hospital of Digestive Diseases, Air Force Medical University | China

Author Profile

Scopus

Orcid ID

🔬 MIN CHEN: LEADING EXPERT IN GASTROENTEROLOGY AND INFLAMMATORY BOWEL DISEASE

EARLY ACADEMIC PURSUITS 🎓

MIN CHEN began her medical journey with a deep-rooted interest in gastrointestinal diseases and internal medicine. Her early academic years were marked by rigorous training in clinical medicine, laying a strong foundation for a future in gastroenterology. She pursued her education in prestigious medical institutions in China, developing a keen focus on digestive tract disorders and later honing her expertise in inflammatory bowel disease (IBD) through both academic and clinical pathways.

PROFESSIONAL ENDEAVORS 🩺

MIN CHEN currently serves as a Chief Physician in the Department of Gastroenterology at Xijing Hospital, affiliated with the Air Force Medical University, a leading medical institution in China. Her career is defined by excellence in clinical care, leadership in medical societies, and contributions to national research networks.

She holds numerous prestigious professional memberships:

• Member, Psychological Cooperation Group of Chinese IBD Association

• Member, Gastroenterology Committee of Chinese Medical and Health Development Foundation

• Standing Member, Youth Gastroenterology Committee of Chinese Medical and Health Development Foundation

• Member, Early Gastric Cancer and Helicobacter pylori Committee, Chinese Association of Integrated Traditional Chinese and Western Medicine

• Member, Gastroenterology Committee of Shaanxi Research Hospital Association

These roles highlight her dedication to advancing gastroenterological care and supporting interdisciplinary approaches in both Western and Traditional Chinese Medicine.

CONTRIBUTIONS AND RESEARCH FOCUS ON INFLAMMATORY BOWEL DISEASE🧪

MIN CHEN is widely recognized for her expertise in the diagnosis and treatment of inflammatory bowel disease (IBD). Her research encompasses both clinical practices and basic scientific investigations, exploring mechanisms of gastrointestinal inflammation, patient-centered care models, and the integration of psychological support in chronic digestive illnesses.

Her work contributes to:

• Improved clinical protocols for IBD management

• Enhanced early detection of gastric cancers

• Broader understanding of the interaction between gut microbiota and immune response

She actively collaborates on national research projects and participates in medical foundations that prioritize the holistic treatment of GI diseases, including mental health support for patients.

IMPACT AND INFLUENCE 🌏

MIN CHEN’s clinical leadership and scientific contributions have had a profound impact on the gastroenterology landscape in China. She has played a pivotal role in:

• Shaping guidelines for IBD diagnosis and care

• Mentoring junior physicians and researchers

• Promoting the integration of Traditional Chinese Medicine with modern GI practices

Her involvement in various national committees amplifies her voice in policymaking and knowledge dissemination across hospitals and research centers in China.

ACADEMIC CITES AND SCHOLARLY INFLUENCE 📚

While specific citation metrics are not provided here, MIN CHEN is recognized for her published contributions in national gastroenterology journals and her presentations at medical conferences. Her research is frequently referenced by peers focusing on:

• IBD clinical management strategies

• Psychological approaches in chronic GI care

• Early detection and treatment of gastrointestinal cancers

She has helped expand the academic dialogue between Western and Chinese traditional medical approaches, enhancing their clinical synergies.

LEGACY AND FUTURE CONTRIBUTIONS 🌟

MIN CHEN's legacy is rooted in her multidisciplinary approach to gastroenterology, combining clinical expertise, research acumen, and holistic patient care. As a prominent voice in Chinese gastroenterology, she continues to:

• Influence health policy and research directions

• Lead training programs for the next generation of gastroenterologists

• Advance integrative medicine by promoting the synergy of Western and traditional practices.

NOTABLE PUBLICATIONS📑

"Analysis of clinical features of 29 adult patients with eosinophilic gastroenteritis" 

• Authors: X., Zhao, Xingyu , M., Chen, Min , X., Ren, Xiaoxia , Y., Shi, Yongquan Zhonghua Nei Ke Za Zhi
• Journal: Chinese Journal of Internal Medicine
• Year: 2025

"Advances in the diagnosis and treatment of eosinophilic gastroenteritis" 

• Authors: M., Chen, Min , Y., Shi, Yongquan Zhonghua Nei Ke Za Zhi
• Journal: Chinese Journal of Internal Medicine
• Year: 2025

"Comparative Effectiveness of Dual Biologic Therapy and Biologic Small-Molecule Therapy for Refractory Inflammatory Bowel Disease: A Retrospective Single-Center Study" 

• Authors: F., Yin, Fan , X., Liu, Xiaolei , D., He, Dongdong, Y., Shi, Yongquan , M., Chen, Min
• Journal: Chinese Journal of Internal Medicine
• Year: 2025